Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy
This trial is active, not recruiting.
|Start date||April 2014|
|End date||July 2015|
|Trial size||25 participants|
|Trial identifier||NCT02067351, 13-008531|
There is evidence that mindfulness-based interventions (MBIs) such as meditation, mindfulness-based stress reduction (MBSR) and yoga might improve Quality of Life (QOL) and reduce stress in breast cancer survivors. These interventions are becoming increasingly popular in cancer survivors. However, little is known about the feasibility and effect of MBIs administered during the interval of time of chemotherapy, on QOL and stress. The investigators are planning a MBI intervention study developed specifically for breast cancer survivors receiving chemotherapy (usually 4-5 months) at the investigators institution, for at least 8 sessions combined with at least 8 weeks of home-practice, in 25 women receiving chemotherapy for breast cancer.
|Endpoint classification||efficacy study|
|Intervention model||single group assignment|
|Primary purpose||supportive care|
Feasibility - percentage of patients recruited from those approached, percentage of patients who dropped off, percentage of patients who are compliant (attending more than 75% of recommended sessions)
time frame: While receiving chemotherapy (usually 4-5 months)
Stress - measured by the Perceived Stress Scale - statistically and clinically significant reductions in stress
time frame: 7-8 months
Female participants from 20 years up to 75 years old.
inclusion criteria: - Women 20-75 years old - Diagnosed with breast cancer - Scheduled to begin chemotherapy at Mayo Clinic Rochester Exclusion criteria - Pregnant - Practicing mindfulness
|Official title||Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy|
|Principal investigator||Daniela Stan, MD|
Call for more information